Donor-specific HLA antibodies: evaluating the risk for graft loss in renal transplant recipients with isotype switch from complement fixing IgG1/IgG3 to noncomplement fixing IgG2/IgG4 anti-HLA alloantibodies

scientific article published on 31 October 2013

Donor-specific HLA antibodies: evaluating the risk for graft loss in renal transplant recipients with isotype switch from complement fixing IgG1/IgG3 to noncomplement fixing IgG2/IgG4 anti-HLA alloantibodies is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/TRI.12206
P698PubMed publication ID24118579

P2093author name stringBernd M Spriewald
Aliki G Iniotaki
Ilias I N Doxiadis
John N Boletis
Marie-Luise Arnold
Irma-Sofia Ntokou
P2860cites workImmunoglobulin-G subclass antidonor reactivity in transplant recipients.Q34351600
Mechanism and regulation of class switch recombinationQ34764888
The link between major histocompatibility complex antibodies and cell proliferationQ35223952
Antibody-mediated renal allograft rejection: diagnosis and pathogenesisQ36759900
HLA class I antibody-mediated endothelial and smooth muscle cell activationQ37430871
Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killingQ40694990
Distinct expression of interleukin 17, tumor necrosis factor α, transforming growth factor β, and forkhead box P3 in acute rejection after kidney transplantation.Q43609726
Detection and specification of noncomplement binding anti-HLA alloantibodiesQ45158306
Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with chronic rejection and graft loss after liver transplantation.Q46174297
Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft moleculesQ47272995
Skewing of pretransplant anti-HLA class I antibodies of immunoglobulin G isotype solely toward immunoglobulin G1 subclass is associated with poorer renal allograft survivalQ47331305
C4d fixing, luminex binding antibodies - a new tool for prediction of graft failure after heart transplantation.Q50899566
Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allograftsQ51038604
P433issue3
P921main subjectantibodyQ79460
P304page(s)253-261
P577publication date2013-10-31
P1433published inTransplant InternationalQ15762140
P1476titleDonor-specific HLA antibodies: evaluating the risk for graft loss in renal transplant recipients with isotype switch from complement fixing IgG1/IgG3 to noncomplement fixing IgG2/IgG4 anti-HLA alloantibodies
P478volume27

Reverse relations

cites work (P2860)
Q58718244Anti-HLA Donor-Specific IgG Subclasses and C1q-binding Evolution in Posttransplant Monitoring
Q28076193Antibody Subclass Repertoire and Graft Outcome Following Solid Organ Transplantation
Q39366396Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies
Q92712461Characterization of the C1q-Binding Ability and the IgG1-4 Subclass Profile of Preformed Anti-HLA Antibodies by Solid-Phase Assays
Q54969814Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis.
Q38923388Follicular T helper cells and humoral reactivity in kidney transplant patients
Q38341785Humoral immunity in renal transplantation: epitopes, Cw and DP, and complement-activating capability--an update
Q36417907IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury
Q37527388Increased CD40 Ligation and Reduced BCR Signalling Leads to Higher IL-10 Production in B Cells From Tolerant Kidney Transplant Patients
Q99413308Investigating the relationship between class I HLA-specific immunoglobulin-G subclasses, Pan-IgG single antigen bead assays and complement mediated interference in sera from renal transplant recipients
Q51585363Kidney Intragraft Homing of De Novo Donor-Specific HLA Antibodies Is an Essential Step of Antibody-Mediated Damage but Not Per Se Predictive of Graft Loss.
Q27314948Monocyte recruitment by HLA IgG-activated endothelium: the relationship between IgG subclass and FcγRIIa polymorphisms
Q39217968Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection
Q92558904Recombinant human monoclonal HLA antibodies of different IgG subclasses recognising the same epitope: Excellent tools to study differential effects of donor-specific antibodies
Q37611251Renal Transplant Patients Biopsied for Cause and Tested for C4d, DSA, and IgG Subclasses and C1q: Which Humoral Markers Improve Diagnosis and Outcomes?
Q30397251The Humoral Theory of Transplantation: Epitope Analysis and the Pathogenicity of HLA Antibodies

Search more.